Carl Zeiss Meditec (ETR:AFX) has been given a €123.00 ($143.02) price objective by Deutsche Bank in a research note issued on Monday, Borsen Zeitung reports. The firm currently has a “buy” rating on the stock. Deutsche Bank’s price objective would indicate a potential upside of 8.85% from the stock’s previous close.
Other analysts have also issued reports about the company. Berenberg Bank set a €93.00 ($108.14) target price on Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Friday, December 6th. HSBC set a €98.00 ($113.95) target price on Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Tuesday, September 17th. DZ Bank reaffirmed a “neutral” rating on shares of Carl Zeiss Meditec in a report on Friday, October 25th. Independent Research set a €89.00 ($103.49) target price on Carl Zeiss Meditec and gave the stock a “sell” rating in a report on Thursday, October 24th. Finally, Hauck & Aufhaeuser set a €110.00 ($127.91) target price on Carl Zeiss Meditec and gave the stock a “buy” rating in a report on Thursday, October 24th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company’s stock. Carl Zeiss Meditec has an average rating of “Hold” and a consensus target price of €100.86 ($117.28).
Carl Zeiss Meditec stock opened at €113.00 ($131.40) on Monday. The firm has a market cap of $10.11 billion and a price-to-earnings ratio of 66.00. Carl Zeiss Meditec has a 52 week low of €65.80 ($76.51) and a 52 week high of €112.70 ($131.05). The business’s 50-day moving average price is €103.50 and its 200 day moving average price is €97.82. The company has a quick ratio of 3.09, a current ratio of 4.11 and a debt-to-equity ratio of 4.55.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
See Also: Do Tariffs Work?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.